Market Movers: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Coach, Inc. (NYSE:COH), Ltd. (NASDAQ:WIX), Constellium N.V (NYSE:CSTM), Central Valley Community Bancorp (NASDAQ:CVCY)

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), announced financial and operational results for the quarter ended June 30, 2015. DCR-PH1: DCR-PH1 is a DsiRNA-EX-based therapeutic candidate for Primary Hyperoxaluria Type 1 (PH1), a severe, rare genetic disease of liver metabolism that often results in life-threatening damage to the kidneys. In a genetic mouse model of PH1, Dicerna has shown that DCR-PH1 knocks down the activity of the HAO1 gene transcript that encodes for the enzyme glycolate oxidase, thereby significantly reducing the production of oxalate, the key disease pathology of PH1. Similar results, if obtained in PH1 patients, may have significant clinical benefit. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) belongs to Healthcare sector. Its weekly performance is -2.70%. On last trading day company shares ended up $11.89. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) distance from 50-day simple moving average (SMA50) is -16.67%.

Women prefer Coach, Inc. (NYSE:COH) leather handbags to those of its major rivals, but they are less impressed by their lofty price. That was a key finding of a survey conducted by J.P. Morgan of 500 women between the ages of 22 and 55 who have purchased a handbag in the past year. Coach was selected most as “brand of choice,” but customers displayed low awareness of changes made to the product line to boost growth. In terms of styling and quality, 72% said that Coach’s product was “unchanged. Coach, Inc. (NYSE:COH) shares moved up 4.78% in last trading session and ended the day at $33.07. COH Gross Margin is 69.60% and its return on assets is 12.10%. Coach, Inc. (NYSE:COH) quarterly performance is -13.20%. Ltd. (Nasdaq:WIX), a leading global web development platform, today reported financial results for the second quarter ended June 30, 2015.Our innovative products and technology platform answers a clear and constantly growing market need and continued to generate strong growth in premium subscriptions, collections and revenue in the second quarter. I am also happy to report that we achieved positive adjusted EBITDA and free cash flow for the first time in our history, a significant milestone,” said Avishai Abrahami, CEO and Co-founder of Wix.On 07 August, Ltd. (NASDAQ:WIX) shares decreased -0.74% and was closed at $21.55. Ltd. (NASDAQ:WIX) year to date (YTD) performance is 2.62%.

Constellium N.V. (NYSE:CSTM) reported results for the second quarter ended June 30, 2015. Highlights below are in comparison to the second quarter of 2014. Constellium’s second quarter 2015 results include a record Adjusted EBITDA in our AS&I segment and better than anticipated results in our A&T business. We also achieved record shipments and Adjusted EBITDA in P&ARP due to the acquisition of Wise Metals inJanuary 2015. Constellium N.V (NYSE:CSTM) ended the last trading day at $6.54. Company weekly volatility is calculated as 28.22% and price to cash ratio as 1.43. Constellium N.V (NYSE:CSTM) showed a weekly performance of -41.08%.

Central Valley Community Bancorp (NASDAQ:CVCY) begin trading ex-dividend on August 05, 2015. A cash dividend payment of $0.06 per share is scheduled to be paid on August 21, 2015. Shareholders who purchased CVCY prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 20% increase over the same period a year ago. Central Valley Community Bancorp (NASDAQ:CVCY) shares decreased -1.07% in last trading session and ended the day at $11.12. Its return on assets is 0.50%. Central Valley Community Bancorp (NASDAQ:CVCY) quarterly performance is 1.00%.

Leave a Reply

Your email address will not be published. Required fields are marked *